- Trials with a EudraCT protocol (47)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
47 result(s) found for: Cerebral circulation.
Displaying page 1 of 3.
EudraCT Number: 2015-002721-18 | Sponsor Protocol Number: AC-054-203 | Start Date*: 2016-02-17 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | ||||||||||||||||||
Full Title: A prospective, multi-center, open-label, single-arm, Phase 2 study to assess the efficacy and safety of clazosentan in reversing angiographically-confirmed cerebral vasospasm in adult subjects with... | ||||||||||||||||||
Medical condition: Aneurysmal subarachnoid hemorrhage (aSAH); cerebral vasospasm | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001338-27 | Sponsor Protocol Number: 2014-001338-27 | Start Date*: 2014-06-19 |
Sponsor Name:Helsinki University Central hospital | ||
Full Title: Influence of propofol and desfluran on the cerebral circulation and recovery after anesthesia | ||
Medical condition: Carotid endarterectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001673-40 | Sponsor Protocol Number: 2015/96 | Start Date*: 2015-06-29 |
Sponsor Name:Oslo University Hospital | ||
Full Title: INTRATHECAL CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING | ||
Medical condition: Cerebrospinal fluid circulation disorder seen in the following clinical disease states: Communicating hydrocephalus, idiopathic intracranial hypertension, idiopathic intracranial hypotension, intra... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016057-17 | Sponsor Protocol Number: 23349 | Start Date*: 2011-07-14 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Gentofte Hospital | ||||||||||||||||||||||||||||||||||||||
Full Title: Behandling med nerveaktiverende medicin efter apopleksi - måling af genoptræningseffekt, patologisk træthed, muskelstyrke og knogleafkalkning | ||||||||||||||||||||||||||||||||||||||
Medical condition: Apopleksi. | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004433-24 | Sponsor Protocol Number: 59498 | Start Date*: 2017-05-17 |
Sponsor Name:Leids Universitair Medisch Centrum | ||
Full Title: ACE inhibition in Fontan patients: its effect on body fluid regulation. | ||
Medical condition: Patients with univentricular hearts palliated by the Fontan procedure | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005749-18 | Sponsor Protocol Number: B01-02 | Start Date*: 2013-08-29 | |||||||||||||||||||||
Sponsor Name:Athersys, Inc | |||||||||||||||||||||||
Full Title: Double-Blind, Randomized, Placebo-Controlled, Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke | |||||||||||||||||||||||
Medical condition: acute ischemic stroke | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000281-36 | Sponsor Protocol Number: HHSC/003 | Start Date*: 2007-05-11 |
Sponsor Name:Imperial College London | ||
Full Title: A Phase I/II safety and tolerability study following autologous infusion of adult haematopoietic cells to patients with acute total anterior circulation ischaemic stroke | ||
Medical condition: Acute Total Anterior Circulation Ischaemic Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006731-31 | Sponsor Protocol Number: tandem-1 | Start Date*: 2008-05-19 | |||||||||||
Sponsor Name:Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol | |||||||||||||
Full Title: Estudio doble ciego, aleatorizado, controlado con placebo de dosis escaladas de deferoxamina intravenosa en pacientes con ictus isquémico agudo tratado con activador tisular del plasminógeno. Doubl... | |||||||||||||
Medical condition: La deferoxamina es un neuroprotector en modelos animales de isquemia/reperfusión cerebral. Si la deferoxamina es segura y bien tolerada en pacientes con ictus agudo puede significar una nueva estra... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001279-19 | Sponsor Protocol Number: SONAS2018 | Start Date*: 2019-08-19 | |||||||||||
Sponsor Name:BURL Concepts, Inc. | |||||||||||||
Full Title: Evaluation of the SONAS® ultrasound device for the assessment of bilateral cerebral perfusion in subjects with acute stroke | |||||||||||||
Medical condition: Acute large vessel occlusion (LVO) stroke (NIHSS score: ≥ 10) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000939-31 | Sponsor Protocol Number: JDS_2021_5 | Start Date*: 2021-11-02 |
Sponsor Name:Hôpital Fondation A. de Rothschild / Service de recherche clinique | ||
Full Title: Efficacy of dornase alfa (Pulmozyme®) on arterial recanalization in post-thrombectomy angiography in patients managed for ischemic stroke by thrombolysis and eligible for thrombectomy: a monocentri... | ||
Medical condition: cerebral thrombectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007031-41 | Sponsor Protocol Number: BIAS1.0 | Start Date*: 2009-09-17 | ||||||||||||||||||||||||||
Sponsor Name:Center for Stroke Research Berlin - Charité Universitätsmedizin Berlin | ||||||||||||||||||||||||||||
Full Title: Beta-Blocker in Acute Ischemic Stroke – a prospective, randomized, double-blinded, placebo-controlled safety and efficacy trial of early treatment | ||||||||||||||||||||||||||||
Medical condition: Acute ischemic stroke in the A. cerebri media territory | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-009357-22 | Sponsor Protocol Number: 08/0257 | Start Date*: 2009-03-09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A phase IV randomised, placebo controlled, double-blind, single centre, out-patient trial to investigate the functional benefit of botulinum toxin injections combined with physiotherapy treatment f... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: upper limb spasticity after stroke | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2021-002076-39 | Sponsor Protocol Number: WC42759 | Start Date*: 2022-02-25 | |||||||||||
Sponsor Name:Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BALOVAPTAN IN PATIENTS WITH ACUTE ISCHEMIC STROKE AT HIGH RISK OF DEVELOPING MALIG... | |||||||||||||
Medical condition: Acute Ischemic Stroke (AIS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001632-28 | Sponsor Protocol Number: GENTLE | Start Date*: 2023-10-24 |
Sponsor Name:Rijnstate | ||
Full Title: Ghrelin in anterior circulation stroke and EVT | ||
Medical condition: acute ischemic stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003870-27 | Sponsor Protocol Number: RA2363 | Start Date*: 2008-10-08 |
Sponsor Name:University of Nottingham | ||
Full Title: ENOS: Efficacy of Nitric Oxide in Stroke. Estudio ENOS: Eficacia del óxido nítrico en el ictus | ||
Medical condition: Hipertensión en el ictus agudo | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) DK (Completed) SE (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001996-13 | Sponsor Protocol Number: Tirofiban-Urokinasi 2007 | Start Date*: 2007-06-06 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Intravenous glycoprotein IIbIIIa inhibitor (Tirofiban) combined with low dose of intra-arterial Urokinase for the endovascolar treatment of patients with acute major ischemic stroke | |||||||||||||
Medical condition: patients with major ischemic stroke not suitable for other authorized treatment for riperfusion of the ischemic area | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000005-23 | Sponsor Protocol Number: Ghreline | Start Date*: 2018-12-12 |
Sponsor Name:University of Twente | ||
Full Title: Ghrelin treatment of comatose patients after cardiac arrest: A clinical trial to promote cerebral recovery | ||
Medical condition: Brain damage after cardiac arrest | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002151-10 | Sponsor Protocol Number: NEUROPROTECTpost-CA | Start Date*: 2015-08-07 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Neuroprotective goal directed hemodynamic optimization in post-cardiac arrest patients: a randomized controlled trial (the NEUROPROTECT post-CA trial) | |||||||||||||
Medical condition: post-cardiac arrest patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002760-41 | Sponsor Protocol Number: CL2-RTCCAR-001 | Start Date*: 2017-09-18 | |||||||||||
Sponsor Name:institute de Recherches Internacionales Servier (promotor internacional) | |||||||||||||
Full Title: Assessment of Active Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) plasma kinetics in Patients at acute stage of Ischemic Stroke: Prospective, Multicentre, Open, Non-randomised, Biomarker Study | |||||||||||||
Medical condition: Acute Ischemic Stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004464-57 | Sponsor Protocol Number: SWIFT-DIRECT | Start Date*: 2019-04-17 |
Sponsor Name:Universtiy Hospital Bern | ||
Full Title: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke | ||
Medical condition: Acute Anterior Circulation Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Ongoing) AT (Completed) GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
